Levi R - Search Results

1

Nitric oxide and peripheral adrenergic neuromodulation.

Levi R, Park KH, Imamura M, Seyedi N, Lander HM. Levi R, et al. Adv Pharmacol. 1995;34:399-413. doi: 10.1016/s1054-3589(08)61100-x. Adv Pharmacol. 1995. PMID: 8562448 No abstract available.

2

Hypoxic coronary vasodilatation and cGMP overproduction are blocked by a nitric oxide synthase inhibitor, but not by a guanylyl cyclase ANF receptor antagonist.

Park KH, Levi R. Park KH, et al. Among authors: levi r. Eur J Pharmacol. 1994 Apr 11;256(1):99-102. doi: 10.1016/0014-2999(94)90622-x. Eur J Pharmacol. 1994. PMID: 7517893

3

Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites.

Park KH, Rubin LE, Gross SS, Levi R. Park KH, et al. Among authors: levi r. Circ Res. 1992 Oct;71(4):992-1001. doi: 10.1161/01.res.71.4.992. Circ Res. 1992. PMID: 1325300

4

Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release.

Seyedi N, Koyama M, Mackins CJ, Levi R. Seyedi N, et al. Among authors: levi r. J Pharmacol Exp Ther. 2002 Aug;302(2):539-44. doi: 10.1124/jpet.302.2.539. J Pharmacol Exp Ther. 2002. PMID: 12130713

5

Norepinephrine release from the ischemic heart is greatly enhanced in mice lacking histamine H3 receptors.

Koyama M, Seyedi N, Fung-Leung WP, Lovenberg TW, Levi R. Koyama M, et al. Among authors: levi r. Mol Pharmacol. 2003 Feb;63(2):378-82. doi: 10.1124/mol.63.2.378. Mol Pharmacol. 2003. PMID: 12527809

6

Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production.

Gross SS, Levi R, Madera A, Park KH, Vane J, Hattori Y. Gross SS, et al. Among authors: levi r. Adv Exp Med Biol. 1993;338:295-300. doi: 10.1007/978-1-4615-2960-6_61. Adv Exp Med Biol. 1993. PMID: 7508166 Review.

7

Unmasking of activated histamine H3-receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release.

Imamura M, Poli E, Omoniyi AT, Levi R. Imamura M, et al. Among authors: levi r. J Pharmacol Exp Ther. 1994 Dec;271(3):1259-66. J Pharmacol Exp Ther. 1994. PMID: 7527852

8

Functional identification of histamine H3-receptors in the human heart.

Imamura M, Seyedi N, Lander HM, Levi R. Imamura M, et al. Among authors: levi r. Circ Res. 1995 Jul;77(1):206-10. doi: 10.1161/01.res.77.1.206. Circ Res. 1995. PMID: 7788879

9

Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors.

Imamura M, Lander HM, Levi R. Imamura M, et al. Among authors: levi r. Circ Res. 1996 Mar;78(3):475-81. doi: 10.1161/01.res.78.3.475. Circ Res. 1996. PMID: 8593706

10

Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop.

Imamura M, Smith NC, Garbarg M, Levi R. Imamura M, et al. Among authors: levi r. Circ Res. 1996 May;78(5):863-9. doi: 10.1161/01.res.78.5.863. Circ Res. 1996. PMID: 8620607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters